140 related articles for article (PubMed ID: 38573411)
1. Parametric net influx rate imaging of
Yin H; Liu G; Mao W; Lv J; Yu H; Cheng D; Cai L; Shi H
Ann Nucl Med; 2024 Apr; ():. PubMed ID: 38573411
[TBL] [Abstract][Full Text] [Related]
2. Parametric Net Influx Rate Images of
Ilan E; Sandström M; Velikyan I; Sundin A; Eriksson B; Lubberink M
J Nucl Med; 2017 May; 58(5):744-749. PubMed ID: 27789716
[No Abstract] [Full Text] [Related]
3. Does whole-body Patlak
Fahrni G; Karakatsanis NA; Di Domenicantonio G; Garibotto V; Zaidi H
Eur Radiol; 2019 Sep; 29(9):4812-4821. PubMed ID: 30689031
[TBL] [Abstract][Full Text] [Related]
4. Comparison of parametric imaging and SUV imaging with [
Chen R; Ng YL; Yang X; Zhu Y; Li L; Zhao H; Zhou Y; Huang G; Liu J
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):568-580. PubMed ID: 37792025
[TBL] [Abstract][Full Text] [Related]
5. Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification.
Velikyan I; Sundin A; Sörensen J; Lubberink M; Sandström M; Garske-Román U; Lundqvist H; Granberg D; Eriksson B
J Nucl Med; 2014 Feb; 55(2):204-10. PubMed ID: 24379222
[TBL] [Abstract][Full Text] [Related]
6. Clinical feasibility and impact of fully automated multiparametric PET imaging using direct Patlak reconstruction: evaluation of 103 dynamic whole-body
Dias AH; Pedersen MF; Danielsen H; Munk OL; Gormsen LC
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):837-850. PubMed ID: 32894338
[TBL] [Abstract][Full Text] [Related]
7. Tumor-to-Blood Ratio for Assessment of Somatostatin Receptor Density in Neuroendocrine Tumors Using
Ilan E; Velikyan I; Sandström M; Sundin A; Lubberink M
J Nucl Med; 2020 Feb; 61(2):217-221. PubMed ID: 31302632
[TBL] [Abstract][Full Text] [Related]
8. 68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial.
Etchebehere EC; de Oliveira Santos A; Gumz B; Vicente A; Hoff PG; Corradi G; Ichiki WA; de Almeida Filho JG; Cantoni S; Camargo EE; Costa FP
J Nucl Med; 2014 Oct; 55(10):1598-604. PubMed ID: 25168627
[TBL] [Abstract][Full Text] [Related]
9. Direct inference of Patlak parametric images in whole-body PET/CT imaging using convolutional neural networks.
Zaker N; Haddad K; Faghihi R; Arabi H; Zaidi H
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4048-4063. PubMed ID: 35716176
[TBL] [Abstract][Full Text] [Related]
10. Dynamic
Yin H; Liu G; Tan H; Shi D; Cheng D; Yu H; Shi H
Quant Imaging Med Surg; 2023 Sep; 13(9):5555-5567. PubMed ID: 37711843
[TBL] [Abstract][Full Text] [Related]
11. Impact of Tissue Classification in MRI-Guided Attenuation Correction on Whole-Body Patlak PET/MRI.
Zhuang M; Karakatsanis NA; Dierckx RAJO; Zaidi H
Mol Imaging Biol; 2019 Dec; 21(6):1147-1156. PubMed ID: 30838550
[TBL] [Abstract][Full Text] [Related]
12. First results on kinetic modelling and parametric imaging of dynamic
Sari H; Mingels C; Alberts I; Hu J; Buesser D; Shah V; Schepers R; Caluori P; Panin V; Conti M; Afshar-Oromieh A; Shi K; Eriksson L; Rominger A; Cumming P
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1997-2009. PubMed ID: 34981164
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric dynamic whole-body PSMA PET/CT using [
Dias AH; Jochumsen MR; Zacho HD; Munk OL; Gormsen LC
EJNMMI Res; 2023 Apr; 13(1):31. PubMed ID: 37060394
[TBL] [Abstract][Full Text] [Related]
14. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
Sampathirao N; Basu S
J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Lesion Detectability in Dynamic Whole-Body PET Imaging Using Compartmental and Patlak Parametric Mapping.
Zaker N; Kotasidis F; Garibotto V; Zaidi H
Clin Nucl Med; 2020 May; 45(5):e221-e231. PubMed ID: 32108696
[TBL] [Abstract][Full Text] [Related]
16. Total-body parametric imaging using the Patlak model: Feasibility of reduced scan time.
Wu Y; Feng T; Shen Y; Fu F; Meng N; Li X; Xu T; Sun T; Gu F; Wu Q; Zhou Y; Han H; Bai Y; Wang M
Med Phys; 2022 Jul; 49(7):4529-4539. PubMed ID: 35394071
[TBL] [Abstract][Full Text] [Related]
17. Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors.
Poeppel TD; Binse I; Petersenn S; Lahner H; Schott M; Antoch G; Brandau W; Bockisch A; Boy C
Recent Results Cancer Res; 2013; 194():353-71. PubMed ID: 22918768
[TBL] [Abstract][Full Text] [Related]
18. Can we differentiate histologic subtypes of neuroendocrine tumour liver metastases at a single phase contrast-enhanced CT-correlation with Ga-68 DOTATATE PET/CT findings.
Gulpinar B; Peker E; Soydal C; Araz M; Elhan AH
Br J Radiol; 2020 Feb; 93(1106):20190735. PubMed ID: 31922897
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Analysis of Heterogeneous [
Zhuang M; Karakatsanis NA; Dierckx RAJO; Zaidi H
Mol Imaging Biol; 2019 Apr; 21(2):317-327. PubMed ID: 29956119
[TBL] [Abstract][Full Text] [Related]
20. Dynamic
Ivanidze J; Roytman M; Skafida M; Kim S; Glynn S; Osborne JR; Pannullo SC; Nehmeh S; Ramakrishna R; Schwartz TH; Knisely JPS; Lin E; Karakatsanis NA
Radiol Imaging Cancer; 2022 Mar; 4(2):e210067. PubMed ID: 35275019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
